An association between fibroblast growth factor 21 and cognitive impairment in iron-overload thalassemia

Abstract Although an increased fibroblast growth factor 21 (FGF21) level was related to mild cognitive impairment (MCI) in metabolic syndrome patients, any association regarding FGF21 and MCI in thalassemia patients as well as mechanistic insight are questionable. Therefore, the objectives of this s...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wasan Theerajangkhaphichai, Jirapas Sripetchwandee, Sirawit Sriwichaiin, Saovaros Svasti, Nipon Chattipakorn, Adisak Tantiworawit, Siriporn C. Chattipakorn
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3dfff1659f4844ba8ae09c9265f57103
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3dfff1659f4844ba8ae09c9265f57103
record_format dspace
spelling oai:doaj.org-article:3dfff1659f4844ba8ae09c9265f571032021-12-02T15:51:13ZAn association between fibroblast growth factor 21 and cognitive impairment in iron-overload thalassemia10.1038/s41598-021-87597-x2045-2322https://doaj.org/article/3dfff1659f4844ba8ae09c9265f571032021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-87597-xhttps://doaj.org/toc/2045-2322Abstract Although an increased fibroblast growth factor 21 (FGF21) level was related to mild cognitive impairment (MCI) in metabolic syndrome patients, any association regarding FGF21 and MCI in thalassemia patients as well as mechanistic insight are questionable. Therefore, the objectives of this study were: (1) to investigate the prevalence and associative risk factors of MCI in thalassemia patients, (2) to evaluate the association between levels of FGF21 and MCI in thalassemia patients, and (3) to investigate brain FGF21 signaling in iron-overload thalassemia. Thalassemia patients were enrolled onto the study (n = 131). Montreal cognitive assessment (MoCA) was used to determine cognitive performance. Plasma FGF21 level was determined in all patients. Iron-overload β-thalassemic (HT) mice were used to investigate brain FGF21 level and signaling, the expression of synaptic proteins, and Alzheimer’s like pathology. We found that 70% of thalassemia patients developed MCI. FGF21 level was positively correlated with the MCI. Interestingly, brain FGF21 resistance, as indicated by increased brain FGF21 levels with impaired FGF21 signaling, was found in iron-overload HT mice. The reduced synaptic protein expression and increased Alzheimer’s like pathology were also observed. These suggest that FGF21 may play a role in MCI in thalassemia patients.Wasan TheerajangkhaphichaiJirapas SripetchwandeeSirawit SriwichaiinSaovaros SvastiNipon ChattipakornAdisak TantiworawitSiriporn C. ChattipakornNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Wasan Theerajangkhaphichai
Jirapas Sripetchwandee
Sirawit Sriwichaiin
Saovaros Svasti
Nipon Chattipakorn
Adisak Tantiworawit
Siriporn C. Chattipakorn
An association between fibroblast growth factor 21 and cognitive impairment in iron-overload thalassemia
description Abstract Although an increased fibroblast growth factor 21 (FGF21) level was related to mild cognitive impairment (MCI) in metabolic syndrome patients, any association regarding FGF21 and MCI in thalassemia patients as well as mechanistic insight are questionable. Therefore, the objectives of this study were: (1) to investigate the prevalence and associative risk factors of MCI in thalassemia patients, (2) to evaluate the association between levels of FGF21 and MCI in thalassemia patients, and (3) to investigate brain FGF21 signaling in iron-overload thalassemia. Thalassemia patients were enrolled onto the study (n = 131). Montreal cognitive assessment (MoCA) was used to determine cognitive performance. Plasma FGF21 level was determined in all patients. Iron-overload β-thalassemic (HT) mice were used to investigate brain FGF21 level and signaling, the expression of synaptic proteins, and Alzheimer’s like pathology. We found that 70% of thalassemia patients developed MCI. FGF21 level was positively correlated with the MCI. Interestingly, brain FGF21 resistance, as indicated by increased brain FGF21 levels with impaired FGF21 signaling, was found in iron-overload HT mice. The reduced synaptic protein expression and increased Alzheimer’s like pathology were also observed. These suggest that FGF21 may play a role in MCI in thalassemia patients.
format article
author Wasan Theerajangkhaphichai
Jirapas Sripetchwandee
Sirawit Sriwichaiin
Saovaros Svasti
Nipon Chattipakorn
Adisak Tantiworawit
Siriporn C. Chattipakorn
author_facet Wasan Theerajangkhaphichai
Jirapas Sripetchwandee
Sirawit Sriwichaiin
Saovaros Svasti
Nipon Chattipakorn
Adisak Tantiworawit
Siriporn C. Chattipakorn
author_sort Wasan Theerajangkhaphichai
title An association between fibroblast growth factor 21 and cognitive impairment in iron-overload thalassemia
title_short An association between fibroblast growth factor 21 and cognitive impairment in iron-overload thalassemia
title_full An association between fibroblast growth factor 21 and cognitive impairment in iron-overload thalassemia
title_fullStr An association between fibroblast growth factor 21 and cognitive impairment in iron-overload thalassemia
title_full_unstemmed An association between fibroblast growth factor 21 and cognitive impairment in iron-overload thalassemia
title_sort association between fibroblast growth factor 21 and cognitive impairment in iron-overload thalassemia
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/3dfff1659f4844ba8ae09c9265f57103
work_keys_str_mv AT wasantheerajangkhaphichai anassociationbetweenfibroblastgrowthfactor21andcognitiveimpairmentinironoverloadthalassemia
AT jirapassripetchwandee anassociationbetweenfibroblastgrowthfactor21andcognitiveimpairmentinironoverloadthalassemia
AT sirawitsriwichaiin anassociationbetweenfibroblastgrowthfactor21andcognitiveimpairmentinironoverloadthalassemia
AT saovarossvasti anassociationbetweenfibroblastgrowthfactor21andcognitiveimpairmentinironoverloadthalassemia
AT niponchattipakorn anassociationbetweenfibroblastgrowthfactor21andcognitiveimpairmentinironoverloadthalassemia
AT adisaktantiworawit anassociationbetweenfibroblastgrowthfactor21andcognitiveimpairmentinironoverloadthalassemia
AT siriporncchattipakorn anassociationbetweenfibroblastgrowthfactor21andcognitiveimpairmentinironoverloadthalassemia
AT wasantheerajangkhaphichai associationbetweenfibroblastgrowthfactor21andcognitiveimpairmentinironoverloadthalassemia
AT jirapassripetchwandee associationbetweenfibroblastgrowthfactor21andcognitiveimpairmentinironoverloadthalassemia
AT sirawitsriwichaiin associationbetweenfibroblastgrowthfactor21andcognitiveimpairmentinironoverloadthalassemia
AT saovarossvasti associationbetweenfibroblastgrowthfactor21andcognitiveimpairmentinironoverloadthalassemia
AT niponchattipakorn associationbetweenfibroblastgrowthfactor21andcognitiveimpairmentinironoverloadthalassemia
AT adisaktantiworawit associationbetweenfibroblastgrowthfactor21andcognitiveimpairmentinironoverloadthalassemia
AT siriporncchattipakorn associationbetweenfibroblastgrowthfactor21andcognitiveimpairmentinironoverloadthalassemia
_version_ 1718385628082601984